Search - tctmd.com

Displaying 181 - 196 of 196

Sort: Relevancy | Date

Presentation ACC 2012

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Presenter: Robert A. Byrne

March 24, 2012

Presentation

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

Presenter: 202206|M Natsuaki

March 04, 2012

Presentation

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Presenter: Takeshi Kimura

January 08, 2012

Presentation TCT 2012

Three Year Outcomes Of Chronic Total Occlusion Treatment With Biolimus Eluting Biodegradable Polymer Stent Versus Sirolimus Eluting Permanent Polymer Stent In the LEADERS...

Presenter: Joanna J. Wykrzykowska, Patrick Serruys, Ton de Vries, Gerrit-Anne Van Es, Pawel Buszman, Axel Linke, Thomas Ischinger, Volker Klauss, Roberto Corti, Franz Eberli, William Wijns, Marie-Claude Morice, Robert Jan van Geuns, Peter Juni, Stephan Windecker, Carlo DiMario

January 03, 2012

Presentation TCT 2012

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, Satoshi Shizuta, Toru Kita, Takeshi Kimura

January 03, 2012

Presentation TCT 2012

Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model

Presenter: Li Shen, Qibing Wang, Yizhe Wu, Jian Xie, Junbo Ge

January 03, 2012

Presentation TCT 2012

Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.

Presenter: Lisbeth Antonsen, Per Thayssen, Henrik Steen Hansen, Michael Maeng, Hans-Henrik Tilsted, Evald Hoej Christiansen, Knud Noerregaard Hansen, Hans Erik Boetker, Jan Ravkilde, Lars Krusell, Morten Madsen, Henrik Toft Soerensen, Leif Thuesen, Jens Flensted Lassen, Lisette Okkels Jensen

January 03, 2012

Presentation TCT 2012

NOYA I: A Prospective Randomized Trial of NOYA Sirolimus-Eluting Stent with Biodegradable Coating Compared to FIREBIRD 2 Sirolimus-Eluting Stent with Durable Coating in...

Presenter: Kefei Dou, Bo Xu, Yuejin Yang, Shuzheng Lu, Lefeng Wang, Haichang Wang, Zhanquan Li, Lei Wang, Guoying Zhu, Wei Li, Run-Lin Gao

January 03, 2012

Presentation TCT 2012

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Presenter: James P. Howard, Zia Buckhoree, Dan A. Jones, Sean M. Gallagher, Krishnaraj S. Rathod, Ajay K. Jain, Charles Knight, Anthony Mathur, Andrew Wragg

January 03, 2012

Presentation TCT 2012

Neointimal Hyperplasia and Peristent Vascular Remodeling after Implantation of Everolimus-eluting Stent versus Sirolimus-eluting Stent. Intravascular Ultrasound Results from...

Presenter: Young-Guk Ko, Dong-Ho Shin, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Myeong-Ki Hong, Hyeon-Cheol Gwon, Taehoon Ahn, In-Ho Chae, Jung-Han Yoon, Hyo-Soo Kim, Yangsoo Jang

January 03, 2012

Presentation TCT 2012

Long-term follow up of sirolimus-eluting stent(SES) implanted in coronary bifurcation lesion: Insight from OCT observations

Presenter: Hirotoshi Hariki, Junya Shite, Toshiro Shinke, Hiromasa Ootake, Masayuki Nakagawa, Ryouji Nagoshi, Takumi Inoue, Tsuyoshi Oosue, Amane Kozuki, Masamichi Iwasaki, Yu Taniguchi, Hiroto Kinutani, Akihide Konishi, Ryo Nishio, Noritoshi Hiranuma, Ken-ichi Hirata

January 03, 2012

Presentation TCT 2012

In-vivo Assessment of Neoatherosclerosis after Sirolimus-eluting Stent implantation: Comparisons of Serial Optical Coherence Tomography Findings between Early and Late Follow-up.

Presenter: Amane Kozuki, Junya Shite, Toshiro Shinke, Hiromasa Otake, Masayuki Nakagawa, Ryoji Nagoshi, Takumi Inoue, Tsuyoshi Osue, Hirotoshi Hariki, Masamichi Iwasaki, Yu Taniguchi, Hiroto Kinutani, Akihide Konishi, Ryo Nishio, Noritoshi Hiranuma, Ken-ichi Hirata

January 03, 2012

Presentation TCT 2012

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

Presenter: Kensuke Takagi, Alfonso Ielasi, Joanne Shannon, Azeem Latib, Cosmo Godino, Giedrius Davidavicius, Marco Mussardo, Santo Ferrarello, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Sunao Nakamura, Antonio Colombo

January 03, 2012

Presentation TCT 2012

Evaluation of Neointimal Healing of EPC-Capturing Sirolimus-Eluting COMBO Stent by Optical Coherence Tomography: The EGO-COMBO Pilot Study (interim results)

Presenter: Stephen W. Lee, Simon C. Lam, Kelvin K. Chan, Michael K. Wong, Frankie C. Tam, Anthony Y. Wong, Arthur Yung, Yui-Ming Lam, Shun-Ling Kong, Raymond H. Chan, Hiram Bezzera, Daniel Chamie, Marco Costa

January 03, 2012

Presentation TCT 2012

Eight Years Clinical Outcomes After Unrestricted Sirolimus-eluting Stent Implantation for Severe Coronary Artery Disease

Presenter: Alfonso Ielasi, Azeem Latib, Marco Mussardo, Massimo Ferraro, Maria Angela Gullace, Cosmo Godino, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Antonio Colombo

January 03, 2012

Presentation TCT 2012

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

Presenter: Enno Boudriot, Holger Thiele, Franz J. Neumann, Michael Gick, Bruno Reichard, Peter Boekstegers, Harald Mudra, Florian Beier, Thomas Walther, Friedrich W. Mohr, Gerhard Schuler

January 03, 2012

Advertisement

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Three Year Outcomes Of Chronic Total Occlusion Treatment With Biolimus Eluting Biodegradable Polymer Stent Versus Sirolimus Eluting Permanent Polymer Stent In the LEADERS...

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model

Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.

NOYA I: A Prospective Randomized Trial of NOYA Sirolimus-Eluting Stent with Biodegradable Coating Compared to FIREBIRD 2 Sirolimus-Eluting Stent with Durable Coating in...

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Neointimal Hyperplasia and Peristent Vascular Remodeling after Implantation of Everolimus-eluting Stent versus Sirolimus-eluting Stent. Intravascular Ultrasound Results from...

Long-term follow up of sirolimus-eluting stent(SES) implanted in coronary bifurcation lesion: Insight from OCT observations

In-vivo Assessment of Neoatherosclerosis after Sirolimus-eluting Stent implantation: Comparisons of Serial Optical Coherence Tomography Findings between Early and Late Follow-up.

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

Evaluation of Neointimal Healing of EPC-Capturing Sirolimus-Eluting COMBO Stent by Optical Coherence Tomography: The EGO-COMBO Pilot Study (interim results)

Eight Years Clinical Outcomes After Unrestricted Sirolimus-eluting Stent Implantation for Severe Coronary Artery Disease

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content